Get the Stockscreener App
110.17
0.10%
-0.06
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $110.17, with a volume of 4.16M.
It is down -0.10% in the last 24 hours and down -7.95% over the past month.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
See More
Previous Close:
$110.23
Open:
$111.52
24h Volume:
4.16M
Relative Volume:
0.38
Market Cap:
$272.14B
Revenue:
$64.93B
Net Income/Loss:
$18.26B
P/E Ratio:
15.14
EPS:
7.2751
Net Cash Flow:
$12.36B
1W Performance:
-2.17%
1M Performance:
-7.95%
6M Performance:
+26.53%
1Y Performance:
+32.37%
1-Day Range:
$109.88
$111.91
1-Week Range:
$109.88
$115.02
52-Week Range:
$73.31
$125.14
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, AZN, NVS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
110.19 | 272.25B | 64.93B | 18.26B | 12.36B | 7.2751 |
LLY
Lilly Eli Co
|
872.13 | 775.68B | 65.18B | 20.64B | 5.96B | 22.59 |
JNJ
Johnson Johnson
|
227.65 | 542.44B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
197.85 | 349.12B | 61.16B | 4.19B | 17.82B | 2.3614 |
AZN
Astrazeneca Plc
|
186.81 | 290.80B | 58.80B | 10.24B | 8.98B | 3.2788 |
NVS
Novartis Ag Adr
|
144.84 | 275.14B | 54.72B | 14.02B | 15.32B | 7.1855 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-25-26 | Initiated | RBC Capital Mkts | Outperform |
| Feb-20-26 | Initiated | Barclays | Overweight |
| Feb-13-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-26 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-18-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Nov-24-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-13-25 | Initiated | Scotiabank | Sector Outperform |
| Oct-13-25 | Resumed | Citigroup | Neutral |
| Sep-17-25 | Downgrade | Berenberg | Buy → Hold |
| May-14-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-22-25 | Initiated | Cantor Fitzgerald | Neutral |
| Feb-18-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-10-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-08-25 | Downgrade | Truist | Buy → Hold |
| Dec-20-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Buy |
| Dec-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Bulk Filtration Market Report 2026, Competitive Analysis of 3M, Eaton, Parker-Hannifin, Pentair, Merck, Danaher, Mann+Hummel - GlobeNewswire Inc.
Wealthfront Advisers LLC Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
FengHe Fund Management Pte. Ltd. Invests $44.25 Million in Merck & Co., Inc. $MRK - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Sells 825,324 Shares of Merck & Co., Inc. $MRK - MarketBeat
Pictet Asset Management Holding SA Decreases Position in Merck & Co., Inc. $MRK - MarketBeat
Nine baseball teams join Merck to warn fans about bad cholesterol - Stock Titan
Antibiotic Resistance Market to Grow at 5.4% CAGR Reaching USD 12.72 Billion by 2031, Driven by Rising Drug-Resistant Infections and Antimicrobial Innovation: Mordor Intelligence - GlobeNewswire Inc.
Merck & Co., Inc. $MRK Shares Bought by AMG National Trust Bank - MarketBeat
Sun Pharma to acquire Merck spinoff Organon for $11.75B - BioWorld News
Merck: Bullish Setup Into Q1 Earnings - Seeking Alpha
Merck & Co Inc (MRK) Stock Price, Trades & News - GuruFocus
State of Michigan Retirement System Sells 13,300 Shares of Merck & Co., Inc. $MRK - MarketBeat
Comerica Bank Reduces Position in Merck & Co., Inc. $MRK - MarketBeat
D.A. Davidson & CO. Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
Ashton Thomas Private Wealth LLC Sells 49,784 Shares of Merck & Co., Inc. $MRK - MarketBeat
Advisors Capital Management LLC Has $17.34 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Inc. (MRK): One of the Best Low Risk High Growth Stocks to Buy Right Now - Insider Monkey
Teachers Retirement System of The State of Kentucky Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Vanguard Group Inc. Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Supplemental Annuity Collective Trust of NJ - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Sanctuary Advisors LLC - MarketBeat
Impax Asset Management Group plc Decreases Stock Position in Merck & Co., Inc. $MRK - MarketBeat
M&T Bank Corp Sells 1,452,939 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Increased by AEGON ASSET MANAGEMENT UK Plc - MarketBeat
Merck and the Healthcare Sector Rotation Analysis - HarianBasis.co
Merck & Co., Inc. $MRK is Munich Reinsurance Co Stock Corp in Munich's 4th Largest Position - MarketBeat
J.P. Marvel Investment Advisors LLC Has $3.02 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Concurrent Investment Advisors LLC Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Generali Investments Management Co LLC Raises Stock Position in Merck & Co., Inc. $MRK - MarketBeat
China Universal Asset Management Co. Ltd. Sells 19,894 Shares of Merck & Co., Inc. $MRK - MarketBeat
Jim Cramer Says “Merck Is Terrific” - Yahoo Finance
MRK Stock Quote Price and Forecast - CNN
Is Merck & Co. (MRK) One of the Best Bear Market Stocks to Invest in Right Now? - Insider Monkey
Infinimmune and Merck (MRK) Enter into an Antibody Discovery Agreement - Insider Monkey
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, - PharmiWeb.com
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc. - BioSpace
Merck & Co., Inc. $MRK Shares Purchased by Cadinha & Co. LLC - MarketBeat
Arizona State Retirement System Sells 31,306 Shares of Merck & Co., Inc. $MRK - MarketBeat
MRK Stock Price, Quote & Chart | MERCK & CO. INC. (NYSE:MRK) - ChartMill
Merck & Co. Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Merck & Co., Inc. $MRK Shares Sold by Teacher Retirement System of Texas - MarketBeat
United Asset Strategies Inc. Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK) Gains FDA Priority Review for KEYTRUDA Regimen in Muscle-Invasive Bladder Cancer - Insider Monkey
Merck & Co., Inc. $MRK Shares Bought by Caprock Group LLC - MarketBeat
B. Metzler seel. Sohn & Co. AG Increases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK) to Release Earnings on Thursday - MarketBeat
Merck & Co. Inc. (MRK) Poised to Drive R&D and Operational Efficiency via New Google Cloud Agentic AI PartnershipUpside Surprise - Xã Thanh Hà
Merck & Co (MRK) Proxy filing Summary - Quartr
Merck to partner with Google Cloud on AI initiatives - Reuters
Merck & Co., Inc. $MRK Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
KLP Kapitalforvaltning AS Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):